Stable Isotope Labeled Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade

Reference: PX-TA1011-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Description of Ustekinumab Biosimilar - Anti-Human IL-12 IL-23 mAb - Research Grade

General information about Ustekinumab

Ustekinumab is a human monoclonal antibody used to treat psoriasis. It is also approved to treat Crohn’s disease and ulcerative colitis among people who have not responded to more traditional treatments. It is a subcutaneous human interleukin 12 and interleukin 23 antagonist. These are naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders. This product is for research use only.

Product nameStable Isotope Labeled Ustekinumab Biosimilar - Anti-Human IL-12 IL-23 mAb - Research Grade
SourceDrugBank DB05679
SpeciesHuman
Expression systemMammalian cells
Molecular weight148kDa
Purity>90%
BufferPBS pH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsUstekinumab
ReferencePX-TA1011-SIL
Related ProductsPX-P4570,PX-P5123
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1
ClonalityMonoclonal Antibody
SourceDrugBank DB05679
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2
Isotopic Enrichment99%
Stability1 year

Reviews

There are no reviews yet.

Be the first to review “Stable Isotope Labeled Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade”

Your email address will not be published.


1,500.00

OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: